News & Analysis as of

Medicare Biden Administration Legislative Agendas

McDermott+

McDermott+ Check-Up: June 13, 2025

McDermott+ on

THIS WEEK’S DOSE - - Reconciliation Moves Forward. Senate committees continue to release their reconciliation provisions. - NIH Director Testifies on FY 2026 Budget. National Institutes of Health (NIH) Director Bhattacharya...more

Holland & Knight LLP

Holland & Knight Health Dose: February 11, 2025

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

McDermott+

Healthcare Preview for the Week of: January 21, 2025

McDermott+ on

First Official Week of Trump 2.0 - President Trump officially began his second term yesterday. He briefly discussed healthcare in his first inaugural speech, committing to tackle chronic disease and keep children safe,...more

Alston & Bird

Look Ahead to the Week of December 16: One Week to Go

Alston & Bird on

Both the House and Senate are scheduled to depart Washington, DC on Friday but have a long list of tasks to finish before adjourning the 118th Congress. Last week, the House passed the annual defense authorization package,...more

McDermott+

McDermott+ Check-Up: November 15, 2024

McDermott+ on

Congress Returns for Lame Duck Session. The House and Senate returned this week, kicking off the post-election lame duck session. The focus this week was not on legislating, but on organizing for the upcoming 119th Congress,...more

McDermott+

Medicare FFS Regs: Thrills and Chills Under the Trump and Biden Administrations

McDermott+ on

Happy Halloween! In the health policy world, there are two things on everyone’s mind this spooky season: the upcoming election and the major calendar year (CY) 2025 Medicare fee-for-service (FFS) final regs that should be...more

Cozen O'Connor

Cozen Currents: Is Harris the Answer?

Cozen O'Connor on

The Cozen Lens - While it’s becoming ever clearer Vice President Harris is likely to be the Democratic nominee following President Biden’s decision to step aside, it’s less clear what the impact will be on the presidential...more

Mintz - Health Care Viewpoints

DOJ Releases COVID-19 Fraud Enforcement Task Force Report Touting Its Successes and Urging Lawmakers to Enact New Legislation

The government’s continued dedication of resources to investigating and prosecuting fraud against COVID-19 pandemic relief programs appears to have borne fruit according to the results of the COVID-19 Fraud Enforcement Task...more

Holland & Knight LLP

Holland & Knight Health Dose: February 6, 2024

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

Holland & Knight LLP

Holland & Knight Health Dose: October 3, 2023

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

Holland & Knight LLP

Holland & Knight Health Dose: March 14, 2023

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include ... ...more

Akin Gump Strauss Hauer & Feld LLP

Congressional Health Policy Outlook for 2023

The House and Senate convened this week to kick off the 118th Congress. Republicans control the House after four years of a Democratic majority. House Republicans have a very slim majority, with only 222 seats to the...more

White & Case LLP

Five Drug Pricing Issues to Watch in 2023

White & Case LLP on

Despite a busy 2022, drug pricing remains a hot topic at the federal and state levels, with a number of recent developments and trends worth monitoring heading into 2023. In the past year, the FTC increasingly focused on the...more

Akin Gump Strauss Hauer & Feld LLP

Key Medicare Issues to Watch in Lame Duck Session

Washington, D.C. is currently focused on a September continuing resolution (CR) to keep the federal government funded, but it is worth looking ahead to the broader health care horizon and the key Medicare issues that await...more

Clark Hill PLC

Window on Washington – Vol. 6, Issue 31

Clark Hill PLC on

Outlook for This Week in the Nation’s Capital - Congress. After a busy weekend voting on the reconciliation bill, the Senate is now in recess through Labor Day. The House, in recess since late July, returns this week on...more

Holland & Knight LLP

2022 Congressional Outlook and Top 10 Federal Health Policy Issues to Watch

Holland & Knight LLP on

As Congress reconvenes, it faces a packed agenda in a legislative year that will be shortened by the upcoming midterm elections and remains buffeted by the persistent coronavirus pandemic. The list of healthcare priorities is...more

Clark Hill PLC

Window on Washington - Vol. 5, Issue 26

Clark Hill PLC on

Outlook for This Week in the Nation’s Capital - Congress. The House is in session this week, but the Senate is not. The House is set to vote on numerous bills this week, including the INVEST in America Act (H.R. 3684), which...more

Brownstein Hyatt Farber Schreck

Summary and Analysis of Biden Administration’s Newly Released FY 2022 Budget

On Friday, May 28, the Biden administration released its fiscal year (FY) 2022 budget request (“Budget”) and the following accompanying documents. - Fact Sheet. Six-page summary of various proposals in the Budget. -...more

Clark Hill PLC

Window On Washington - Vol. 5, Issue 18

Clark Hill PLC on

Outlook for This Week in the Nation’s Capital - Congress. The Senate is in recess this week, though the House is in session. Hearings for this week include a House Science, Space, and Technology (SST) hearing on climate and...more

Hogan Lovells

Ramping up the drug pricing debate: Dueling bills and paying for health care infrastructure

Hogan Lovells on

The U.S. House of Representatives is considering dueling proposals related to drug pricing under Medicaid and Medicare, including the Republican-led H.R. 19, the “Lower Costs, More Cures Act of 2021” and a reintroduced...more

Clark Hill PLC

Window On Washington - Vol. 5, Issue 15

Clark Hill PLC on

Outlook for This Week in the Nation’s Capital - Congress. The House and Senate are back in session this week. The House is set to consider the Paycheck Fairness Act this week (H.R. 7), which would amend the Fair Labor...more

Clark Hill PLC

Window On Washington - Vol. 5, Issue 13

Clark Hill PLC on

Outlook for This Week in the Nation’s Capital - Congress. The House and Senate are both in recess until the week of April 12, though the House Administration Committee will hold a hearing Thursday on the state of voting in...more

Patrick Malone & Associates P.C. | DC Injury...

Better Healthcare Newsletter from Patrick Malone - February 2021

Health care has dominated national politics for more than a decade. Voters told pollsters it was a top concern heading into the 2020 campaign, and that only intensified with the coronavirus pandemic. As the new...more

Holland & Knight LLP

President Biden Proposes Massive COVID-19 Rescue Plan: Summary and Outlook

Holland & Knight LLP on

President Joe Biden has proposed an "American Rescue Plan," which was described as an "emergency legislative package to fund vaccinations, provide immediate, direct relief to families bearing the brunt of the COVID-19 crisis,...more

Holland & Knight LLP

Healthcare Policy Outlook with a Democratic-Controlled Senate

Holland & Knight LLP on

The victories by Democrats Raphael Warnock and Jon Ossoff in the Georgia elections mean that incoming majority leader Chuck Schumer (D-N.Y.) will preside over the narrowest possible majority in the U.S. Senate under which...more

26 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide